BPC logo

Birzeit Pharmaceuticals Company Stock Price

PLSE:BPC Community·US$149.2m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

BPC Share Price Performance

US$0
-3.65 (-100.00%)
US$0
-3.65 (-100.00%)
Price US$0

BPC Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with proven track record.

2 Risks
2 Rewards

Birzeit Pharmaceuticals Company Key Details

US$48.0m

Revenue

US$30.5m

Cost of Revenue

US$17.4m

Gross Profit

US$5.5m

Other Expenses

US$11.9m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
0.31
36.38%
24.91%
0%
View Full Analysis

About BPC

Founded
1973
Employees
372
CEO
Firas Kathem Nasereddin
WebsiteView website
bpc.ps

Birzeit Pharmaceuticals Company operates as a pharmaceutical manufacturing company in the Palestinian Authority. The company offers OTC products for alimentary system cardiovascular system, central nervous system, musculo-skeletal system, endocrine, genito-urinary system, diabetes, obstetrics and gynecology infections, affecting nutrition and metabolism, respiratory system, ophthalmic drugs, dermatological preparations, and dietary supplements, as well as ear, nose, and oropharynx therapeutic areas. It serves the Ministry of Health, healthcare organizations and programs, and consumers through pharmacies and doctors. The company was founded in 1973 and is headquartered in Ramallah, the Palestinian Authority.

Recent BPC News & Updates

Recent updates

No updates